Therapeutic Advances in Ophthalmology最新文献

{"title":"Scheimpflug imaging for evaluation of intraocular lens position in modified flanged scleral fixated intraocular lens.","authors":"Avadhesh Oli, Anil Yadav, J Ganesh Babu, Divya Balakrishnan","doi":"10.1177/25158414221147208","DOIUrl":"https://doi.org/10.1177/25158414221147208","url":null,"abstract":"<p><strong>Background: </strong>Scleral fixation of intraocular lens (IOLs) is the most preferred technique for the management of aphakia and the techniques have evolved over the years. These methods have their advantages and disadvantages, however, the major concern being the position of the intraocular lens, its stability and complications. The final IOL position is the major determinant of the final visual acuity, and various imaging modalities have been used to quantify the IOL tilt.</p><p><strong>Objectives: </strong>Use of Scheimpflug imaging to evaluate the IOL tilt in modified flanged scleral-fixated intraocular lens (MFSIOL).</p><p><strong>Design: </strong>Retrospective chart review of 41 consecutive patients who underwent MFIOL.</p><p><strong>Methods: </strong>We conducted a retrospective chart review of 41 consecutive patients who underwent MFIOL. The baseline and final best-corrected visual acuity (BCVA), refractive error, and clinical examination findings were recorded. The vertical and horizontal tilts of the IOLs were calculated using the Scheimpflug image. The IOL tilt (in degrees) in the vertical and horizontal axes was the primary outcome and the BCVA, residual refractive error, intraocular pressure, and surgical complications were secondary outcome measures.</p><p><strong>Results: </strong>The mean baseline BCVA was logMAR 0.49, which improved to logMAR 0.356 (<i>p</i> < .005) after the surgery. The mean IOL tilt in the vertical axis was 3.40° (range of 0.0°-8.5°, interquartile range: 1.21-5.66) and in the horizontal axis was 1.35° (range of 0.60°-4.620°, interquartile range: 0.44-1.86), respectively. There was no correlation between angle of IOL tilt and UCVA (<i>r</i> = 0.089, <i>p</i> = 0.580), BCVA (<i>r</i> = 0.109, <i>p</i> = 0.498), final spherical error (<i>r</i> = 0.081, <i>p</i> = 0.615), cylindrical error (<i>r</i> = 0.207, <i>p</i> = 0.195), axial length (<i>r</i> = 0.105, <i>p</i> = 0.514), and IOL power (<i>r</i> = -0.139, <i>p</i> = 0.388).</p><p><strong>Conclusion: </strong>Modified flanged IOL (MFIOL) is an alternative technique for intrascleral fixation of IOL resulting in good lens stability. The IOL tilt achieved by this technique is minimal and did not influence the final visual outcome or spectacle correction. Scheimpflug imaging is simple and non-invasive method to measure the IOL tilt.</p><p><strong>Plain language summary scheimpflug imaging for modified flanged scleral fixated lens position: </strong>This study on 41 eyes was aimed to analyze the lens tilt using Scheimpflug imaging in cases of modified flanged scleral fixation of intraocular lens (MFSFIOL), which is a novel technique to minimize the complications and simplify the procedure. The intraocular lens (IOL) remained stable with an acceptable range of vertical and horizontal tilt. There was no significant effect of IOL tilt on the final best-corrected visual acuity (BCVA) or spectacle correction. Scheimpflug imaging is an accurate and non-invas","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414221147208"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/79/10.1177_25158414221147208.PMC9841840.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10548398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the safety and efficacy of epi-off corneal cross-linking in patients with thin corneas due to keratectasia.","authors":"Abigail Nieuwsma,&nbsp;Brandon L Vander Zee,&nbsp;John P Berdahl,&nbsp;Mitch Ibach,&nbsp;Tanner J Ferguson,&nbsp;Daniel Terveen","doi":"10.1177/25158414231197064","DOIUrl":"https://doi.org/10.1177/25158414231197064","url":null,"abstract":"<p><strong>Background: </strong>Corneal cross-linking (CXL) is a safe and effective procedure for slowing keratectasia progression in eyes with a corneal thickness of at least 400 µm. Limited research has evaluated the safety and efficacy of epi-off CXL in corneas thinner than 400 µm.</p><p><strong>Objective: </strong>To evaluate the safety and efficacy of CXL to slow keratectasia progression in eyes with <400 µm preoperative corneal thickness.</p><p><strong>Design: </strong>Retrospective chart review.</p><p><strong>Methods: </strong>This retrospective chart review included 37 eyes who underwent epi-off, iso-osmolar riboflavin corneal CXL with a preoperative thinnest point of the cornea <400 µm and had at least 6-12 months of follow-up. Preoperative and postoperative uncorrected visual acuity, best-corrected visual acuity (BCVA), thinnest point of the cornea, flat keratometry, steep keratometry, maximum keratometry (K_max), need for penetrating keratoplasty, and cases of endothelial failure were recorded. Data were collected at baseline and months 3, 6, 9, and 12 post-CXL.</p><p><strong>Results: </strong>Following cross-linking, 18 eyes (47%) had improved BCVA, 13 (35%) had an unchanged BCVA, and 6 eyes (16%) had a worse BCVA (<i>p</i> = 0.05). The mean postoperative BCVA was 20/81 (0.61 LogMAR) compared to 20/121 (0.78 LogMAR) preoperatively (<i>p</i> = 0.06). K_max decreased an average of 1.1 D at 3-month (<i>p</i> = 0.53) and 3.4 D at the furthest follow-up (<i>p</i> = 0.10). At the farthest follow-up, 22.7% of eyes had >1 D of K_max steepening. No patients required keratoplasty and there were no cases of endothelial failure in the follow-up period.</p><p><strong>Conclusion: </strong>This research supports the safety and efficacy of epi-off, iso-osmolar CXL in eyes with <400 μm baseline corneal thickness with no patients requiring penetrating or endothelial keratoplasty, a trend toward improvement in BCVA, and K_max flattening. In the future, prospective studies would be helpful to confirm these findings.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231197064"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/49/b5/10.1177_25158414231197064.PMC10504847.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10309626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis.","authors":"Bhawesh Chandra Saha,&nbsp;Rashmi Kumari,&nbsp;Anita Ambasta","doi":"10.1177/25158414231173532","DOIUrl":"https://doi.org/10.1177/25158414231173532","url":null,"abstract":"<p><strong>Background: </strong>Topical immunosuppressants such as tacrolimus in different concentrations are a breakthrough in the management of recalcitrant vernal keratoconjunctivitis (VKC); however, there is a lacks of comparative studies to guide their use in VKC management.</p><p><strong>Objective: </strong>To compare the efficacy and safety of tacrolimus 0.03% and 0.1% eye ointment in the treatment of recalcitrant VKC.</p><p><strong>Design: </strong>A retrospective comparative single-centre observational study.</p><p><strong>Method: </strong>We reviewed records of a total of 48 recalcitrant VKC patients treated with two different strengths of tacrolimus ointment between April 2016 and March 2017. Of these, 39 fulfilled the inclusion criteria and were categorized into two groups, A and B, depending on the use of strength of tacrolimus (0.03% and 0.1%) used, respectively. Group A had 18 patients, while group B had 21 patients. Thirty-six patients, 18 from each group, were finally analysed and compared. Records of patients were explored for the subjective symptoms and objective sign score of the patient at baseline and at each time point. The main outcome measures were composite scoring and comparison of total subjective symptom scores (TSSSs) and total objective sign scores (TOSSs) within and between the groups at each follow-up. Percentage of patient with significant reduction in symptom and sign scores as compared with baseline was considered success of treatment. Chi-square and <i>t</i>-tests were used for comparison of outcomes between both groups.</p><p><strong>Results: </strong>Mixed variety was most commonly encountered type of VKC. The signs and symptoms were significantly reduced in patients with treatment in both groups (<i>p</i> = 0.001) in all types of VKC. However, in group B, there was significant improvement in the size of papillae (<i>p</i> = 0.04) as compared baseline in contrast to group A. Side effects like burning and stinging in group B were significantly higher as compared with group A.</p><p><strong>Conclusions: </strong>Both strengths of tacrolimus (0.03% and 0.1%) are effective in all forms of recalcitrant VKC. Papillary component of VKC responds better with higher strength (0.1%) but is associated with more significant side effects. Different strengths of tacrolimus can be used strategically depending upon the severity and clinical type of VKC to intensify outcome and minimize side effects.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231173532"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/31/10.1177_25158414231173532.PMC10226287.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9556811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The impact of obesity on ocular hemodynamics and choroidal thickness.","authors":"Melek Tufek,&nbsp;Pinar Nalcacioglu,&nbsp;Mustafa Capraz,&nbsp;Kenan Varol,&nbsp;Ahmet Turan Kaya,&nbsp;Nihat Aydın,&nbsp;Caner Kara","doi":"10.1177/25158414231180985","DOIUrl":"https://doi.org/10.1177/25158414231180985","url":null,"abstract":"<p><strong>Background: </strong>Obesity affects microvascular structures. The effect of obesity on the ocular vascular system can be evaluated by changes in the choroidal thickness (CT) and retrobulbar blood flow (RBF).</p><p><strong>Objectives: </strong>To evaluate the CT and RBF parameters in obese patients with various body mass index (BMI) values and compare these parameters with normal weight, healthy subjects.</p><p><strong>Design: </strong>A prospective study.</p><p><strong>Methods: </strong>The study included 102 eyes of 102 female patients. Patients were divided into three groups according to BMI as group 1 with a BMI of 18.5-24.99 (<i>n</i> = 32), normal weight group; group 2 with a BMI of 30-34.99 (<i>n</i> = 35), as obese class I; and group 3 with a BMI of 35-39.99 (<i>n</i> = 35), as obese class II. The peak systolic velocity (PSV), end-diastolic velocity (EDV), resistive index, and pulsatility index values of the central retinal artery (CRA) and ophthalmic artery (OA) were evaluated with color Doppler ultrasonography. CT was measured at the subfoveal area and at 500-µm intervals nasal and temporal to the fovea up to a distance of 1500 µm by using the enhanced depth imaging technique of optical coherence tomography. Intraocular pressure (IOP) was measured with a Goldmann applanation tonometry.</p><p><strong>Results: </strong>There was a significant difference in IOP values within the groups with the highest values in group 3 (17.6 ± 2.1 mmHg) and the lowest in group 1 (12.4 ± 1.7 mmHg). The CT in groups 2 and 3 was found to be statistically significantly lower than that in group 1 at all measurement points (<i>p</i> < 0.001). There was a statistically significant negative correlation between CT at all measurement points and BMI (<i>p</i> < 0.001). The mean CRA PSV, EDV, and OA EDV values were statistically significantly lower in each obese group than those values in group 1 (<i>p</i> < 0.001). The OA PSV values were significantly lower in group 3 (36.5 ± 5.9 cm/s) than those in group 2 (43.8 ± 4 cm/s) and group 1 (44.6 ± 5.2 cm/s) (<i>p</i> < 0.001). Also, significant associations were found between BMI and CRA PSV, CRA EDV, and OA PSV values (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Obesity may predispose to eye pathologies by changing the ocular vascular circulation.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231180985"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dd/4d/10.1177_25158414231180985.PMC10333989.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10193732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to \"Three-dimensional printing in ophthalmology and eye care: current applications and future developments\".","authors":"","doi":"10.1177/25158414231154423","DOIUrl":"https://doi.org/10.1177/25158414231154423","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1177/25158414221106682.].</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231154423"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/11/cb/10.1177_25158414231154423.PMC9932750.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9331483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment of non-infectious retinal vasculitis.","authors":"Paola A Rivera,&nbsp;Akash Gupta,&nbsp;Ninani Kombo","doi":"10.1177/25158414231152761","DOIUrl":"https://doi.org/10.1177/25158414231152761","url":null,"abstract":"<p><p>Retinal vasculitis (RV) refers to an entity in which the retinal vasculature is inflamed, frequently with indications of inflammation elsewhere in the eye. Non-infectious RV can be idiopathic or associated with systemic disease, ocular conditions, and malignancy. It can also be classified based on the vessel affected: artery, vein, or both. Due to the lack of strong evidence-based treatment trials and algorithms for RV, physicians must often rely on their experience, which creates great variability in treating this entity. This article provides an overview of various treatment modalities used in the management of non-infectious RV, with a focus on immunomodulatory therapies. We outline a potential stepwise approach of starting with steroids to control the acute inflammation and subsequently changing to immunomodulatory therapy (IMT) for long-term treatment.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231152761"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/14/10.1177_25158414231152761.PMC10107051.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9378149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"YouTube as a source of patient information for pterygium surgery.","authors":"Cem Ozturkmen,&nbsp;Mustafa Berhuni","doi":"10.1177/25158414231174143","DOIUrl":"https://doi.org/10.1177/25158414231174143","url":null,"abstract":"<p><strong>Background: </strong>Patients use the YouTube platform to get information about pterygium surgery, and this affects the treatment decisions of the patients.</p><p><strong>Objectives: </strong>The purpose of this study was to analyze the quality and reliability of YouTube videos as educational resources about pterygium surgery.</p><p><strong>Design: </strong>This is a register-based retrospective study.</p><p><strong>Methods: </strong>This was a retrospective, record-based study. A YouTube search was performed using the terms 'pterygium surgery' and 'pterygium eye surgery', resulting in the evaluation of a total of 200 videos. In the end, 122 English-language videos about pterygium surgery were recruited to study. All videos were rated with the DISCERN, the <i>Journal of the American Medical Association</i> (JAMA), and the Global Quality Score (GQS) systems.</p><p><strong>Results: </strong>The mean DISCERN, JAMA, and GQS values were 38.9 ± 10.9, 1.8 ± 0.8, and 2.2 ± 1, respectively. The YouTube videos about pterygium surgery had been uploaded by a physician in 63 (51.6%) and non-physicians in 59 (48.4%) cases. There was no significant difference between the two groups in terms of general characteristics and scores.</p><p><strong>Conclusions: </strong>Our results show that YouTube videos about pterygium surgery have low quality and credibility and are not sufficient in terms of providing patient information.</p><p><strong>Registration: </strong>Not applicable.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231174143"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/68/10.1177_25158414231174143.PMC10226336.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9606341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of oxidative damage in cataract etiopathogenesis.","authors":"Enes Atalay,&nbsp;Tevfik Oğurel,&nbsp;Mehmet Kürşat Derici","doi":"10.1177/25158414231168813","DOIUrl":"https://doi.org/10.1177/25158414231168813","url":null,"abstract":"<p><strong>Background: </strong>Cataract usually occurs due to age and diabetes, but the mechanisms of cataract formation have not yet been fully elucidated. In this study, the relationship between cataract and oxidative stress was evaluated by examining the aqueous humor reflecting lens metabolism.</p><p><strong>Objective: </strong>In this study, the effect of oxidative stress on the etiopathogenesis of cataract was investigated through the total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), and arylesterase (ARE) levels in aqueous humor samples of patients with cataract.</p><p><strong>Design: </strong>A prospective cohort study.</p><p><strong>Methods: </strong>This study was conducted on patients who were scheduled for cataract surgery between June 2020 and March 2021. The patients were divided into four groups according to their cataract density as grades 1, 2, 3, and 4. TOS, TAS, and ARE levels of aqueous humor samples were measured spectrophotometrically, and comparisons were made between groups.</p><p><strong>Results: </strong>A total of 100 eyes of 100 patients were included in this study. TAS levels were found significantly higher in the grade 2 group compared with the grade 4 group (<i>p</i> = 0.006). In addition, a significant negative correlation was present between cataract grade and TAS level (<i>r</i> = -0.237; <i>p</i> = 0.018). There was no significant difference between diabetic and nondiabetic patients in terms of TAS, TOS, OSI, and ARE levels.</p><p><strong>Conclusion: </strong>The aqueous humor of patients with a high degree of cataract is characterized by low antioxidant capacity. Decreased antioxidant capacity has a role in cataract formation and progression.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231168813"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/9a/10.1177_25158414231168813.PMC10161335.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9424123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detailed intraocular pressure curve by telemetric tonometry with an implanted pressure sensor before and after PreserFlo^® MicroShunt implantation: a case report.","authors":"Caroline Julia Gassel,&nbsp;Dimitar Nikolov Dzhelebov,&nbsp;Bogomil Voykov","doi":"10.1177/25158414221149927","DOIUrl":"https://doi.org/10.1177/25158414221149927","url":null,"abstract":"<p><p>Continuous control of intraocular pressure (IOP) is crucial to preventing long-term damage to the optic nerve in glaucoma. Recently, a novel telemetric IOP sensor (EYEMATE-IO™, Implandata Ophthalmic Products GmbH, Hannover, Germany) has been developed that continuously records IOP. The patient can read the IOP measurements wirelessly using a hand-held reading device. We present the case of a 70-year-old patient with primary open-angle glaucoma who had been implanted with an EYEMATE-IO™ and recently underwent minimally invasive bleb-filtering surgery with the PreserFlo^® MicroShunt (Santen, Osaka, Japan). This case demonstrates both the benefits of continuous pressure measurement with EYEMATE-IO™ and the ability of the PreserFlo^® MicroShunt to significantly reduce IOP fluctuations.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414221149927"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/e1/10.1177_25158414221149927.PMC9875318.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10584248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The multiprobe: a revolutionary concept for vitreoretinal surgery.","authors":"Lorenzo Iuliano,&nbsp;Marco Codenotti","doi":"10.1177/25158414231173533","DOIUrl":"https://doi.org/10.1177/25158414231173533","url":null,"abstract":"Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Ther Adv Ophthalmol","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"15 ","pages":"25158414231173533"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/a8/10.1177_25158414231173533.PMC10201168.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9517167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}